Dale Chappell

Person

Nidwalden, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Method of increasing the efficacy of CAR-T immunotherapy using lenz...
- Patent number 11,673,962
- Issue date Jun 13, 2023
- HUMANIGEN, INC.
- Cameron Durrant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating CART-T cell therapy-induced neuroinflammation u...
- Patent number 11,130,805
- Issue date Sep 28, 2021
- HUMANIGEN, INC.
- Cameron Durrant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing tumor relapse rate in immunotherapy by administr...
- Patent number 10,927,168
- Issue date Feb 23, 2021
- HUMANICEN, INC.
- Cameron Durrant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing the level of non-GM-CSF cytokines/chemokines in...
- Patent number 10,899,831
- Issue date Jan 26, 2021
- HUMANIGEN, INC.
- Cameron Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating immunotherapy-related toxicity using a GM-CSF a...
- Patent number 10,870,703
- Issue date Dec 22, 2020
- HUMANIGEN, INC.
- Cameron Durrant
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20220025034
- Publication date Jan 27, 2022
- Humanigen, Inc.
- Cameron DURRANT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20210322547
- Publication date Oct 21, 2021
- Humanigen, Inc.
- Cameron DURRANT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20210290677
- Publication date Sep 23, 2021
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20210269518
- Publication date Sep 2, 2021
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20210230262
- Publication date Jul 29, 2021
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20210130488
- Publication date May 6, 2021
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20200354443
- Publication date Nov 12, 2020
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20190338023
- Publication date Nov 7, 2019
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20190322735
- Publication date Oct 24, 2019
- Humanigen, Inc.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20190284271
- Publication date Sep 19, 2019
- HUMANIGEN, INC.
- Cameron DURRANT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...
- Publication number 20190194343
- Publication date Jun 27, 2019
- Humanigen, Inc.
- Cameron DURRANT
- C07 - ORGANIC CHEMISTRY

Dale Chappell

Person

Patents Grantslast 30 patents

Method of increasing the efficacy of CAR-T immunotherapy using lenz...

Methods of treating CART-T cell therapy-induced neuroinflammation u...

Method of reducing tumor relapse rate in immunotherapy by administr...

Method of reducing the level of non-GM-CSF cytokines/chemokines in...

Methods of treating immunotherapy-related toxicity using a GM-CSF a...

Patents Applicationslast 30 patents

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF A...